SCHEMBL14224525

SCHEMBL14224525

CN(C)CCCn1cc(NC(=O)c2cc3ccccc3cn2)cc1C(=O)Nc1cc(-c2nc3ccncc3[nH]2)n(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.35
MAPK1 P28482 2/20 0.35
CBLB Q13191 7/20 0.35
PRKCA P17252 3/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
HPSE Q9Y251 2/20 0.34
EGFR P00533 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
PDGFRB P09619 1/20 0.33
KIT P10721 1/20 0.33
PDGFRA P16234 1/20 0.33
FLT3 P36888 1/20 0.33
FTO Q9C0B1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14224524 0.93 MAPT (0.37) MAPTMAPK1CBLBPRKCAHPSE
SCHEMBL14224526 0.90 CBLB (0.36) CBLBPRKCAHDAC1HDAC2HDAC8
SCHEMBL14426984 0.88 MAPT (0.41) MAPTMAPK1CBLBHPSEEGFR
SCHEMBL14224527 0.88 CBLB (0.36) CBLBPRKCAHDAC1HDAC2HDAC8
SCHEMBL14224756 0.84 MAPT (0.42) MAPTMEN1POLBKMT2A
SCHEMBL14224801 0.84 CYP11B2 (0.39) MAPTPRKCAHDAC1HDAC2HDAC8
SCHEMBL14224550 0.84 HDAC1 (0.34) MAPTMAPK1PRKCAHDAC1HDAC2
SCHEMBL14224803 0.79 FPR1 (0.42) MAPTMAPK1PRKCAMEN1POLB
SCHEMBL14224802 0.78 MAPT (0.41) MAPTMAPK1PRKCAPOLBTDP1
SCHEMBL14224795 0.77 FPR1 (0.34) MAPTMAPK1PRKCAHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 MAPT 4305/4885MAPK1 4075/4885CBLB 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.